Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Panel meeting prompts excitement for antiobesity drug.

Mullard A.

Lancet. 2012 Mar 10;379(9819):882. No abstract available.

PMID:
22413140
2.

Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.

Bays H.

Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1777-801. doi: 10.1586/erc.10.125. Epub 2010 Aug 16. Review.

PMID:
20707765
3.

Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.

Bays HE, Gadde KM.

Drugs Today (Barc). 2011 Dec;47(12):903-14. doi: 10.1358/dot.2011.47.12.1718738. Review. Erratum in: Drugs Today (Barc). 2012 Jan;48(1):95.

PMID:
22348915
4.

New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).

Shyh G, Cheng-Lai A.

Cardiol Rev. 2014 Jan-Feb;22(1):43-50. doi: 10.1097/CRD.0000000000000001. Review.

PMID:
24304809
5.

Phentermine and topiramate extended-release for the obesity: new kids on the block.

Katsi V, Marketou M, Kallistratos MS, Tousoulis D, Makris T, Manolis AJ, Vardas P, Kallikazaros I.

Recent Pat Cardiovasc Drug Discov. 2013 Apr;8(1):35-41. Review.

PMID:
23565717
6.

Fixed-dose combination of phentermine-topiramate for the treatment of obesity.

Halpern B, Faria AM, Halpern A.

Expert Rev Clin Pharmacol. 2013 May;6(3):235-41. doi: 10.1586/ecp.13.13. Review.

PMID:
23656337
7.
8.

Combination phentermine/topiramate for obesity treatment in primary care: a review.

Xiong GL, Gadde KM.

Postgrad Med. 2014 Mar;126(2):110-6. doi: 10.3810/pgm.2014.03.2746. Review.

PMID:
24685974
9.

Overview of new antiobesity drugs.

Hainer V.

Expert Opin Pharmacother. 2014 Oct;15(14):1975-8. doi: 10.1517/14656566.2014.946904. Epub 2014 Aug 6. Review.

PMID:
25100293
10.

Drug treatment of obesity in the cardiovascular patient.

Charakida M, Tousoulis D, Finer N.

Curr Opin Cardiol. 2013 Sep;28(5):584-91. doi: 10.1097/HCO.0b013e3283642a4c. Review.

PMID:
23928924
11.

New pharmacological treatments for the management of obesity.

Hurt RT, Edakkanambeth Varayil J, Ebbert JO.

Curr Gastroenterol Rep. 2014;16(6):394. doi: 10.1007/s11894-014-0394-0. Review.

PMID:
24828101
12.

A review of the metabolic effects of controlled-release Phentermine/Topiramate.

Kiortsis DN.

Hormones (Athens). 2013 Oct-Dec;12(4):507-16. Review.

13.

The pharmacological and surgical management of adults with obesity.

Ryan DH.

J Fam Pract. 2014 Jul;63(7 Suppl):S21-6. Review. No abstract available.

PMID:
25198216
14.

Obesity consults--comprehensive obesity management in 2013: understanding the shifting paradigm.

Kushner RF, Apovian CM, Fujioka K.

Obesity (Silver Spring). 2013 Nov;21 Suppl 2:S3-13; quiz S14-5. doi: 10.1002/oby.20627. Review.

15.

In brief: Phentermine (Lomaira) for weight loss.

[No authors listed]

Med Lett Drugs Ther. 2016 Dec 5;58(1509):158. Review. No abstract available.

PMID:
27906152
16.

Phentermine/topiramate for the treatment of obesity.

Smith SM, Meyer M, Trinkley KE.

Ann Pharmacother. 2013 Mar;47(3):340-9. Review.

PMID:
23482732
17.

[Cutting-edge of medicine; the prospects of novel anti-obesity drugs].

Ueno H, Nakazato M.

Nihon Naika Gakkai Zasshi. 2014 Mar 10;103(3):753-9. Review. Japanese. No abstract available.

PMID:
24796150
18.

Pharmaceutical treatment of obesity.

Blackburn GL, Miller D, Chan S.

Nurs Clin North Am. 1997 Dec;32(4):831-48. Review.

PMID:
9386228
19.

Medical treatment of obesity: the past, the present and the future.

Bray GA.

Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):665-84. doi: 10.1016/j.bpg.2014.07.015. Epub 2014 Aug 8. Review.

PMID:
25194183
20.

Pharmacological approaches to intervention.

Guy-Grand B.

Int J Obes Relat Metab Disord. 1997 Mar;21 Suppl 1:S22-4. Review.

PMID:
9130037

Supplemental Content

Support Center